New Ford EV lineup priced from $30,000 to widen appeal

Med-X is more than a natural pesticide company – it’s a fast-growing player in the $17 billion pest control industry, and it’s preparing for a major leap: a potential listing on the Nasdaq under the ticker MXRX.

But here’s the thing – your opportunity isn’t after the bell rings. It’s now.

Founded with a mission to bring safer, plant-based alternatives to market, Med-X has already generated over $6.4 million in revenue in the last four years. Its flagship Nature-Cide product line has outperformed conventional chemical pesticides in independent tests for certain use cases and is trusted by pest control professionals and national retailers alike.

Available today through ecommerce leaders Walmart, Amazon, and Kroger as well as extensive commercial distribution partnerships.
Registered in Mexico, Singapore, Thailand and expanding internationally into 41+ markets.
Formulated to meet growing demand for natural, eco-friendly pest control.
Aligned with global sustainability and public health trends.

While many startups are still in development mode, Med-X has real-world traction.

Their products are trusted by professionals and being used in the field – used in commercial, residential, public health, aerial and organic food production applications.

As climate change, regulation, and consumer demand continue pushing the pesticide industry toward natural solutions, Med-X stands positioned as a category leader with an active customer base and scalable manufacturing.

What makes this moment unique? The company is preparing for a Nasdaq direct listing – and shares are currently available at $4.00 through a Regulation A+ offering.

Med-X is targeting a clean, repeat-revenue business model that sits at the intersection of sustainability, public health, and scalable consumer retail.

[Review the full Med-X investment opportunity]

This is a company already solving real problems, with real customers, and a clear path to expansion. Don’t wait until the direct listing headlines hit. Look closer now.

Disclosures

This is a paid advertisement for Med-X’s Regulation A+ Offering.
Please read the offering circular at invest.medx-rx.com

Disclaimer: This is a paid advertisement for informational and educational purposes only and does not constitute financial advice. Investing involves risk and may not be suitable for all individuals. Past performance does not guarantee future results. Active Trader Daily is operated by Active Trader Media, LLC. We are not licensed financial advisors. Always consult with a certified financial professional before making investment decisions.

IMPORTANT NOTICE AND DISCLAIMER: Active Trader Media, LLC (“ATD”), the owner of this website (the “Website”), cannot guarantee the accuracy or completeness of the information contained in any article, email, newsletter, or other publication posted on or viewed in connection with this website (the “Publications”). The author or authors of those Publications are solely responsible for their contents. ATD has not done any research or due diligence into the markets, industries, or companies which may appear or be mentioned in the Publications. ATD will NOT be liable for any loss or damage caused by a reader’s reliance on information posted on the Website or contained in the Publications.

FOR EDUCATIONAL AND INFORMATIONAL PURPOSES ONLY; NOT INVESTMENT ADVICE: This Website and the Publications are for educational and informational purposes only. This Website and the Publications do not purport to be a complete analysis of any company’s financial position. This Website, the Publications or any statements made in the Publications are not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. This Website or the statements made in the Publications should NOT be relied upon for purposes of transacting in any securities posted on the Website or mentioned in the Publications, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security posted on this Website or mentioned in any Publications.

SUBSTANTIAL RISK IN INVESTMENT: Any individual who chooses to invest in any securities including those mentioned in the Publications should do so with caution. Investing or transacting in securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers bear responsibility for their own investment research and decisions and should review all investment decisions with a licensed or registered investment professional.

NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER: Neither ATD nor any of its respective owners or employees are registered or licensed as a securities broker-dealer, broker, an investment advisor, or an investment advisor representative with the U.S. Securities and Exchange Commission (SEC), any state securities regulatory authority, or any self-regulatory organization.

To view our full policies: Disclaimer | Privacy Policy | Terms & Conditions

Active Trader Daily
203 N La Salle Street, Suite 2100 | Chicago, IL 60601